“…The current interest in 4H-chromene derivatives arises from their potential application as antimicrobial (Kuarm et al, 2011;Rai et al, 2010), anti-HIV (Bhavsar et al, 2011;Park et al, 2008), anti tubercular (Kamdar et al, 2010), antioxidant (Singh et al, 2010), anticancer (Raju et al, 2011), antitumor (Huang et al, 2009), cytotoxic agent (Raj et al, 2010;Sabry et al, 2011), antidyslipidemic agent (Sashidhara et al, 2008), antileishmanial (Nazarian et al, 2010), anti inflametory (Gebhardt et al, 2007), antihelicobacter pylori agent (Chimenti et al, 2007), and TNF-a inhibitor (Cheng et al, 2003).…”